Endovaskulinių specialistų asociacija - financials and debts

Company age: 12 y. 9 mo.

Update

Company finances

EUR
2018
From: 2018-01-01
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue - - - 1,980 82,260 64,443 184,086 51,130
Profit before tax - - - - 0 0 36,562 -10,231
Net profit - - - - 0 0 36,562 -10,231
Equity 0 0 0 20,207 32,209 0 60,810 51,072
Liabilities 8,382 - 5,640 5,640 580 5,561 4,230 1,164
Non-current assets 0 - 0 0 0 - 0 0
Current assets 29,258 - 21,675 25,847 32,789 - 65,040 52,236
Total assets 29,258 0 21,675 25,847 32,789 0 65,040 52,236
Financial indicators
Revenue change y/y - - - - +4054.5% -21.7% +185.7% -72.2%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. - - - - 0.0% - 56.2% -19.6%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. - - - - 0.0% - 60.1% -20.0%
Profit margin Net profit margin. Shows the overall profitability of the company. - - - - 0.0% 0.0% 19.9% -20.0%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. - - - - 0.0% 0.0% 19.9% -20.0%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. - - - 0.3 0.0 - 0.1 0.0
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. - - - - - - - -

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Social security debts

The company had no debts to Sodra

VMI tax arrears

The company had no tax arrears (debts) to the State Tax Inspectorate

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Endovaskuliniu specialistu asociacija (code 303207637) is an Association operating in activities of other membership organisations n.e.c. In 2025, the latest financial year, revenue amounted to EUR 51.1K, down 72.2% year on year from EUR 184.1K in 2024. The company reported a net loss of EUR 10.2K in 2025, compared with a net profit of EUR 36.6K in 2024, which indicates a clear deterioration in operating performance. The 2025 profit margin was -20.0%, while ROE and ROA were -20.0% and -19.6%, respectively. Over the two-year period, revenue remained above the 2023 level of EUR 64.4K, but fell sharply from the 2024 peak. At the balance sheet date in 2025, total assets were EUR 52.2K, equity EUR 51.1K and liabilities EUR 1.2K. The equity ratio stood at 97.8%, debt-to-equity at 0.02, and asset turnover at 0.98x, reflecting a very lightly leveraged structure and moderate use of assets to generate revenue.